Clinical utility of the IHC4+C score in oestrogen receptor-positive early breast cancer: a prospective decision impact study

BACKGROUND: Most oestrogen receptor (ER)-positive early breast cancer diagnosed today is highly curable with multimodality treatment. Systemic adjuvant treatments including endocrine therapy and chemotherapy have made a significant contribution to the increasing cure rates over the past three decade...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Cancer
Autors principals: Yeo, B, Zabaglo, L, Hills, M, Dodson, A, Smith, I, Dowsett, M
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2015
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4522631/
https://ncbi.nlm.nih.gov/pubmed/26180920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.222
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars